StockData
ATECNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Alphatec Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$10.41−0.05 (-0.48%)

Close on Oct 19, 2026

Market cap
$1.63B
P/E (TTM)
–
Dividend yield
–

Alphatec Holdings, Inc. revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015% of revenueYoY
Products and Services$764.16M$611.56M$482.26M$350.87M$242.26M$141.08M––––100.0%+25.0%
United States Product–––––$141.08M$108.24M$83.66M$86.93M–––
International Supply Agreement–––$15.00K$954.00K$3.78M$5.19M$8.04M$14.81M–––

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015% of revenueYoY
United States$716.14M$571.27M$445.35M$326.70M$223.91M$141.08M–––$114.58M93.7%+25.4%
International$48.01M$40.30M$36.91M$24.17M$19.30M$3.78M–––$70.70M6.3%+19.2%
Japan–––––––––$33.00M––

From the segment and revenue-disaggregation notes of Alphatec's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.